Alex Meneshian
Oral and Maxillofacial Surgery · Mineola, NYNPI 1396706412
Payments from drug & device makers
Across 69 payments — averaging $71.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neoss, Inc.$2K
- Biohorizons Implant Systems Inc.$1K
- Keystone Dental Inc.$567
- Dentsply IH Inc.$370
- Zimvie Inc.$237
- AbbVie$189
- plus $345 from 6 others
What the payments were for
- Food & beverage$2,86958%
- Education$752%
- Entertainment$671%
- Other$1,90839%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neoss, Inc. | 4 | $2,019 |
| Biohorizons Implant Systems Inc. | 33 | $1,191 |
| Keystone Dental Inc. | 2 | $567 |
| Dentsply IH Inc. | 4 | $370 |
| Zimvie Inc. | 6 | $237 |
| AbbVie | 7 | $189 |
| Dentsply Sirona Inc | 2 | $102 |
| Nobel Biocare USA | 3 | $66 |
| Orapharma, A Division Of Bausch Health US, LLC | 4 | $57 |
| Thommen Medical USA, LLC | 1 | $55 |
| Straumann USA LLC | 2 | $50 |
| Geistlich Pharma, North America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,919 in reported general payments places this provider in the 90th percentile of 605 oral and maxillofacial surgery providers in New York.
See all oral and maxillofacial surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CefuroximeCefuroxime Axetil | 113 | $1,322 |
| Chlorhexidine Gluconate | 145 | $603 |
| Penicillin V Potassium | 81 | $399 |
| Azithromycin | 56 | $204 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $182 |
| Amoxicillin | 43 | $176 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $168 |
| Clindamycin Hcl | 18 | $138 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in Mineola
- Daniel BuchbinderNew York$422K
- Jay NeugartenLake Success$393K
- Bart SilvermanNew City$310K
- Vasiliki KarlisNew York$201K
- Yan TrokelNew York$86K
- Evan ChafitzYonkers$70K
- Vincent AquinoBuffalo$63K
- Shahin GhobadiMamaroneck$62K
- Michael MarkiewiczBuffalo$61K
- Jairo BastidasBronx$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.